Weill Cornell Medicine Urology
Weill Cornell Medicine Urology
Scott T. Tagawa, M.D.

Scott T. Tagawa, M.D.

Find a Physician

FIND A PHYSICIAN

Quickly search our world-class physicians and faculty by keyword, location and insurance provider.

Search

First Clinical Trial of New Targeted Molecular Therapy in U.S. Takes Aim at Incurable Prostate Cancer

NewYork-Presbyterian and Weill Cornell Medicine clinicians in progress on Phase 1 clinical trial of PSMA-Targeted Therapeutic Agent for the Treatment for Metastatic Prostate Cancer

NewYork-Presbyterian and Weill Cornell Medicine have begun the first clinical trial in the U.S. that uses a small molecule, 177Lu-PSMA-617, to treat men with progressive prostate cancer that has spread beyond the prostate, or is metastatic, and is no longer responding to hormonal therapy.

Scott T. Tagawa

Scott T. Tagawa, MD was initially appointed to the faculty of Weill Cornell Medical College in April, 2007 as Assistant Professor of Medicine and Urology and Assistant Attending Physician in the Division of Hematology and Medical Oncology. He joined the Genitourinary Oncology Program within the Solid Tumor Service in the Division of Hematology and Medical Oncology.

Find a Physician FIND A PHYSICIAN

© 2016 Weill Cornell Medicine All rights reserved.